Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shoot me an email I need your help on formatting charts like you did earlier..
Rolandrickperry@gmail.com
News Related Chart
Trying to create a long-term news chart, first try. Did this once before in a stock we were in for five years - which showed (in hindsight) that the daily/weekly or even monthly gyrations, were not quite as important as they seemed while in the midst of them.
http://www.beveragestockreview.com/new-age-beverages.html
Also working on a very broad Price to Sales beverage industry chart this weekend, covering the industry, including private companies which were acquired.
Bucha: Sweet Taste And A Better Investment Opportunity
New post on SA.
"I gained a close up understanding of why OTCBB companies often have a negative stigma associated with them. At the end of the day, most OTC companies will never be in position to uplist to the NASDAQ or NYSE, but if you uncover a name that's in position to do so, it could turn out to be a very fruitful investment. If you can find an unknown OTC company that is profitable and just acquired a company more than 12 times its size without wrecking the capital structure you have my full attention."
http://seekingalpha.com/article/3980722-bucha-sweet-taste-better-investment-opportunity
Matt Margolis, Wall Street Forensics.
http://wallstreetforensics.com/
We are now New Age Beverages Corporation.
The stockholders executed a written consent on May 23, 2016 approving the proposal that we change our corporate name from Búcha , Inc., to New Age Beverages Corporation. Pursuant to SEC rules and regulations, these actions require notification to all of our stockholders.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11429765
Frank Commanday, Microbiologist.
Let's not forget this is not just a company with symbol and share price, but a company with a product which tastes better than the competition.
Ultimately what drives any beverage company forward, is a superior better tasting product - not press releases, conference calls, or trading volume. With a superior product, that consumers love - everything else will take care of itself. And taste nearly always trumps functionality, with the majority of consumers.
"..the team wanted fizzy beverage regulars, who are used to 30 plus grams of sugar per pop, to be attracted to their version of kombucha.."
Bucha = sweet and delicious. And Frank Commanday, with a master's in microbiology has figured it out.
http://www.foodnavigator-usa.com/Manufacturers/Bucha-wants-to-bridge-sweet-fizzy-beverage-drinkers-to-kombucha?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Frank Commanday is the Head Brewmaster and Chief Technical Officer of búcha® Live Kombucha.
He has been the in charge of all technical operations, research and development, and brewing since the Company’s inception in 2009. He is the key architect of the unique búcha® Live Kombucha formulas and consumer leading taste profiles.
Mr. Commanday has over 25 years of practical brewing experience playing a critical role in the success and development of two of Oregon’s first microbreweries. Prior to búcha,® Mr. Commanday was the Technical Director of start-up company, Golden Star Tea Company where he was able to transfer much of his brewing expertise to the Tea Category. Prior to this, he was the Master Brewer at E&O Trading Company, a San Francisco brewing and restaurant operation.
Since the early ‘80’s, Frank worked in technical, brewing, research and development and quality leadership capacities at Widmer Brothers Brewing Co, Sierra Nevada Brewing Company, and The Portland Brewing Company.
Mr. Commanday received his Bachelor of Arts in Biology from University of California, Santa Cruz and a Masters of Arts in Microbiology from University of California, Davis.
"Bucha Generation"
Bucha could have a lot of marketing fun challenging the current leader GT, like Pepsi did which was against all odds at the time.
The celebrity-laden, youth-oriented “Pepsi Generation” advertising blitz was paired with the Pepsi Challenge, which featured people doing a blind taste test of Pepsi and Coke — and usually choosing Pepsi as tastier. Together, the campaigns helped bolster the company’s market share.
“After 87 years of going at it eyeball to eyeball, the other guy just blinked,” Mr. Enrico said in a full-page advertisement in American newspapers.
Will Bucha make GT blink? Only time will tell !
Let the games begin.
http://www.nytimes.com/2016/06/03/business/roger-enrico-pepsico-obituary.html
------------------------
"...from a demand risk standpoint, with Bucha, we have great category growth… and relatively weak competition. There is a great built-in source of revenue to draw from with one competitor that is $400 million in revenue. We just want our fair share of this – which frankly we define as all of it."
"Well, I am happy to report that we have three sources of competitive advantage: We have a preferred flavor with búcha. In recent independent quantitative research, búcha was ranked as superior in taste vs. competition, with a top two box score, preferred or strongly preferred of 76%, or 43% above competition."
"Why such a significant difference and preference of Bucha? Well, I personally believe most of the Kombucha competitors have an acquired taste. It is quite acidic and vinegary in finish, which frankly is appealing to a subset of consumers. What the research tells us though, is that consumers prefer the mainstream appealing flavor and balance of búcha. It still has the fermented tea notes and kombucha brewed flavor, but because of our proprietary production process – unique in the industry, we end up with an elegant, complex, refreshing, and clean, really beautiful product."
Brent Willis April Conference call.
http://seekingalpha.com/article/3963947-american-brewing-companys-abrw-ceo-brent-willis-q4-2015-results-earnings-call-transcript?part=single
The Bucha Challenge ?
We've tasted Bucha vs GT's (the industry leader) and there is no comparison. This would be fun..
Get into the conversation.
Few people remember that when the Cola Wars began, Pepsi trailed Coke badly, and the brand was struggling. Coke had been wining the image game, using its superior scale, marketing resources and brand leadership to push the number-two cola increasingly into the shadows.
While Enrico was determined to elevate Pepsi’s brand image on par with Coke’s over time, he also knew that the taste-based “Pepsi Challenge” would reinsert his brand back into consumer consideration immediately. The Pepsi Challenge started as a regional promotion conceived by a mid-level manager toiling in Coke-dominated Texas. But Enrico elevated it into a national priority for the brand and used it to cultivate the challenger spirit as the defining element of the company’s culture for many years.
http://fortune.com/2016/06/03/roger-enrico-pepsico/
Water Surpassing Carbonated,
The International Bottled Water Association (IBWA), Alexandria, Va., in conjunction with New York-based Beverage Marketing Corporation (BMC), released 2015 bottled water statistics, which show that Americans’ consumption of bottled water increased by 7.9 percent and bottled water sales are up 8.9 percent from the previous year, according to the companies.
BMC now indicates that bottled water is poised to overtake carbonated soft drinks as America’s largest beverage category by volume by 2017, if not by the end of 2016, it says.
“Consumer demand for bottled water looks likely to remain strong in the years ahead. Increases in per capita consumption indicate enthusiasm for a product that consumers regard as a healthful alternative to other beverages,” said Michael C. Bellas, BMC chairman and chief executive officer, in a statement. “Americans increased their annual consumption by more than 11 gallons, from 25.4 gallons per person in 2005 to 36.5 gallons a decade later.
http://www.bevindustry.com/articles/89334
http://www.beveragestockreview.com/
I Never Do Anything Small..
I was asked to join the Board of Directors of the company and to take on the Interim Chief Executive Officer role, and last week I decided to do so.
Why? Well, I did my due diligence and had others do some for me too and the conclusion was this is a massive opportunity. I never do anything small, and we used to have a saying at AB InBev, that it is as much work to do something, as it is to do something huge - so you might as well go big. No one on the planet believed that we could take a small little Belgian brewer that no one had ever even heard of, and make it into the world’s largest but we did against some pretty strong competitors. This opportunity, with Bucha Live Kombucha, won’t go from $2 Billion to $100 Billion like InBev, but there is no question in my mind that this brand, in this category, in this window of opportunity, is an absolute winner.
http://seekingalpha.com/article/3963947-american-brewing-companys-abrw-ceo-brent-willis-q4-2015-results-earnings-call-transcript
We can take the position as a world leader.
“We can take the position as a world leader in healthy, functional beverages,” Willis told BevNET.
Its distribution might still be nascent, but Bucha’s leadership is thinking big after a merger with Xing Tea.
Brent Willis, the CEO of the publicly traded kombucha company, announced the merger today with Xing, a Colorado-based natural tea line that is also owned by Tom Lebon and Scott Lebon, the brothers who run Denver distribution powerhouse New Age Beverage.
Under the deal, Bucha is paying close to $20 million in cash and stock for XingTea, XingEnergy and Aspen Pure water, enabling the Lebons to buy out longtime silent partner Dan Carney. Under the arrangement, Tom Lebon will remain the head of sales for Xing, while Scott Lebon will run operations for the brand; Willis, who once ran Cott Corp. in addition to several other executive slots with companies like AB InBev and the Coca-Cola Co., will be CEO of the combined entity.
“We can take the position as a world leader in healthy, functional beverages,” Willis told BevNET.
The combined companies believe the partnership will quickly realize about $7.5 million in combined cost savings and revenue expansion in the next 12 to 18 months, with Xing’s sales force driving Bucha through its broader distribution profile, according to Willis.
Bucha will quickly realize distribution through having the brands plugged into the Lebons’ own distribution company, which has about 4,500 accounts in the Rocky Mountain region. Then sales efficiencies will help power more growth for the kombucha brand, which has the advantage of being able to travel at ambient temperatures, according to Willis.
As for Xing, “We’ll have a good partner who can help us strategically,” said Tom Lebon. “It gives us the money to start doing marketing and the things we haven’t been able to do out there.”
The combined entity, New Age Beverage Corporation, will eventually trade as NABC on the OTC exchange, with plans to move to a more senior stock exchange. Currently Bucha itself trades under the ticker symbol ABRW, the remaining legacy of craft brewer American Brewing, which sold its brewing business last year to focus on healthy, functional brands. The sale left the company with positive cash flow — a rarity for the OTC market.
The Lebons have been shopping Xing for the past few years, looking for a way to buy out Carney, an aging co-founder of Pizza Hut who financed the brand’s early growth. Xing is sold in 40 states and internationally, with retail information firm IRI showing sales of close to $14 million in the 52-week period ending Jan. 24, 2016 (those sales totals cover Supermarkets, Drugstores, Mass Market Retailers, Convenience Stores, Military Commissaries and Select Dollar and Club Chains).
The company recently launched XingEnergy and will soon receive non-GMO certification for its teas.
“We’re pretty fired up,” Tom Lebon said of the partnership.
BevNet
https://www.bevnet.com/news/2016/new-age-marriage-bucha-xing-announce-merger
Beverage Stock Review
http://www.beveragestockreview.com/
Beverage Stock Review Magazine
https://flipboard.com/section/beverage-stock-review-bLYhMl
Beverage Stock Review
First profile now on site, along with a couple newsreels from local news Good Morning Phoenix Channel 3 and Fox KSAZ Channel 10.
http://www.beveragestockreview.com/research-reports.html
Watching bottles run by on a conveyor adds an element of reality (and fun) you just can't get anywhere else. Bottle, label, water, capped, boxed, loaded on truck shipped to somewhere USA, unloaded from truck, placed on shelf, consumer buys, pays register, drives home, place in refrigerator, pours themselves a glass - drinks it all - rinse and repeat.
Over and over again. 10's of thousands of times.
It's not quite as exciting as when we were in the Milwaukee Budweiser plant where the bottles flew by so fast, it was impossible to count them - but still cool to see. Made me proud to be an American !
Here's the Budweiser Budvar conveyor.
http://www.gettyimages.com/detail/video/bottles-of-budweiser-budvar-beer-move-along-conveyor-news-footage/495277186
Disclaimer on profile.
Beverage Stock Review Initiates Coverage.
http://internetstockreview.ning.com/profiles/blogs/adding-the-alkaline-water-company-wter-to-watch-list
http://www.beveragestockreview.com/home.html
Diego Pellicer Investment in Plandai.
Note 5 – Investment
In January 2014, the Company entered into an Agreement with Plandai Biotechnology, Inc. (a publicly traded company) to license to them certain intellectual property rights in exchange for warrants to purchase 3,333,334 shares of Plandai Biotechnology, Inc. (“Plandai”) common stock. This license agreement carries a 10-year term with an exercise price of $0.01 per share. The Company is to obtain certain Trademark rights certified by the government (expected by 2 nd quarter 2016). On October 10, 2014 the Company filed its Notice of Exercise to execute the warrants to acquire the shares of Plandai, in which the shares have not yet been issued. The sale of such shares has a “leak out” restriction on them requiring that the sale of such shares must reach a certain traded price of $0.50 per share. The Company used a third party appraisal firm to ascertain the fair value of warrants held by the company, which was determined to be $525,567. With the Plandai shares currently trading at $.07 per share, the Company impaired $408,900 during the year ended December 31, 2015. The Company accounts for its investment under the cost method of accounting.
Can someone fix Customore, I thought is was a clver spelling at first !
We're back.
Maybe. Testing the waters here on the whole group.
http://internetstockreview.ning.com/profiles/blogs/finjan-fnjn-1-25-scores-big-news
https://flipboard.com/@institution73s6/patent-stock-review-bk74l0tsy
Diego Pellicer Added to Watch List.
At the Internet Stock Review.
http://internetstockreview.ning.com/profiles/blogs/adding-diego-pellicer-dpww-0-45-to-watch-list
Not a client !
Internet Stock Review Initiates Coverage.
We've posted profile on our site and a couple videos from the Microsoft developers conference featuring Nelly Porter who is in charge of OS Security and Chris Hallum who is Senior Product Manager for OS Security. It's a bit technical (and long), but shows clearly how Microsoft is moving to a password free world, in favor of biometric solutions.
www.internetstockreview.com
People v Thomas
This case presents the evolving issue of prohibitions on the use of electronic vapor cigarettes in public places. Defendant was using such a device on a subway platform. When the police approached him to issue a summons, defendant declined to provide identification and, [*2]instead, used an obscenity in telling the police to leave him alone. He was placed under arrest!
http://law.justia.com/cases/new-york/other-courts/2016/2016-ny-slip-op-26033.html
Competitor Prices.
https://store5.esellerate.net/store/checkout/CustomLayout.aspx?s=STR4351627810&pc=&page=OnePageCatalog.htm
This were originally made by DigitalPersona, which was acquired by Cross Match and then Cross Match was acquired by Francisco Partners, a $7 billion private equity firm.
Google "DigitalPersona and NCR."
http://www.franciscopartners.com/
Fingerprints Cards Soars 1,391% in 2015.
The stock was a dud for almost 15 years, a technology ahead of its time that got little traction until 2013.
Imagine losing patience with this one in 2014.
The Swedish maker of biometric technology has soared 1,391 percent in 2015 through Monday, the biggest gainer among the some 1,000 companies on the Bloomberg World EMEA Index. With a market value swelling to 32.8 billion kronor ($3.9 billion).
http://internetstockreview.ning.com/profiles/blogs/fingerprint-cards-soars-1-391-europe-s-best-performing-stock-in-2
First, Plandaí does not engage in any stock promotional activities.
Our goal is to build a company, and a stock price, based on a solid business foundation.
http://www.plandaibiotech.com/shareholder-update.html
Well good luck with that when there's companies with better current fundamentals, with greater potential and who haven't suffered through an unfortunate freak hailstorm destroyed most of your final crop.
Yeah and Heinz doesn't advertise its ketchup and Nestle doesn't advertise its water and...
All companies need to reach out to the world (not scam spam) to let it know how things are really going. Good, bad or great - share the news.
Does the company really think people will find it by..how, what ?
Do they think people will magically find a $0.05 stock all on their own and then take the time to read the SEC filings to find out, if they have in fact built a solid business foundation.
That takes, if you're fast, 20 minutes. To randomly look at 12,000 companies would take 240,000 minutes of 4,000 hours or almost a year and a half.
If someone does it alphabetically they will get to PLPL sometime in early 2017.
Plandai, like all companies and all products - needs to invest in letting the world how it exists.
Interesting
Who are these guys ? Interesting shareholders, early players in PETS. Kivilcim, Kizanlikli. Does anyone know Deng Ventures ?
(from an old filing w/ Petmed express PETS}
PetMed went from $1 at the time of the filing to a high of $22 !
GUVEN KIVILCIM, 28, has been a member of our board of directors since
November 2000. Since December 1997, Mr. Kivilcim has been chairman and president
of Radiant Telecom, Inc., a long distance telecommunications company. Mr.
Kivilcim is also a 20% shareholder of Tricon Holdings, LLC, a principle
shareholder of the Company. From 1995
AGK Consulting, Inc. owns the technology and platform that Phonetime operate its business on a day to day basis. Phonetime's management and independent directors believe that it is essential that this software and related know-how be owned by Phonetime. Phonetime have agreed to acquire the software and related hardware from AGK in exchange for 20 million shares at $0.10 per share. Phonetime has obtained an independent appraisal of the value of AGK's software and technology and the purchase process has been led by the independent directors. The purchase is subject to majority of the minority/disinterested shareholder approval and the approval of the TSX.
http://www.sec.gov/Archives/edgar/data/1040130/000094344003000405/xslF345X01/primary_doc.xml
http://web.tmxmoney.com/quote.php?qm_symbol=TEL&locale=EN
12
<PAGE> 13
to present, Mr. Kivilcim has been employed as a vice president with Tel3.com, a
telecommunications company. Mr. Kivilcim is also Secretary & Treasurer of Next
Communications, Inc. Mr. Kivilcim is Mr. Kizanlikli's cousin.
HUSEYIN KIZANLIKLI, 38, has been a member of our board of directors
since November 2000. Since December 1997, Mr. Kizanlikli has been vice president
and a director of Radiant Telecom, Inc., a long distance telecommunications
company, and since October 1996, he as been vice president and a director of
Creslin of Florida, Inc., a real estate corporation established in 1995. Mr.
Kizanlikli is also CEO of a European company, Yesil Kundura, based in Istanbul,
Turkey since 1995. Mr. Kizanlikli is also a director of Managed Vision. Mr.
Kizanlikli is Mr. Kivilcim's cousin.
http://secgems.com/c/0001040130/petmed-express-inc
http://www.sec.gov/Archives/edgar/data/1040130/000095014401001710/g66729sc14f1.txt
---------------------
To make room for the new members, Kenneth Jacobi and Huseyin Kizanlikli have departed the PetMed Express board. The company said they vacated their seats to support the company's goal of creating a more independent board.
PetMed Express did not identify the two remaining board members.
Shares closed 10 cents to $1.85. The 52-week low was 70 cents on Dec. 26. The 52-week high was $2.60 on July 10.
http://www.bizjournals.com/southflorida/stories/2002/11/18/daily51.html
--------------------
FCC stuff
http://licensing.fcc.gov/myibfs/download.do?attachment_key=1080520
-------------------
Natali Dadon ? 876,403 shares.
https://goo.gl/nKZsDV
-------------------
Bootie Beer !
TMT (Tania Mercedes Torruella) Capital Corp. and its subsidiary Freedom Wireless Corp., a provider
of wireless services and solutions, announced that Freedom has
appointed Michael De Prado as President of Sales.
Michael De Prado brings an exceptional track record for driving
revenues and profitability for major growth companies such as,
Theglobe.com, Ntera Holdings and Lucent Technologies, the company noted.
http://biz.yahoo.com/ic/119/119156.html
https://www.sec.gov/litigation/admin/2009/34-59959.pdf
http://www.sec.gov/litigation/suspensions/2013/34-69678.pdf
----------------
On the Closing date, PLKD’s board of directors shall thereafter appoint Arik Maimon, to the PLKD board of directors;
after which the current officers and directors (Robert Rico, Calvin Lewis, Ken Weidrich) will resign from their positions
with PLKD
----------------
No position
The Chances of Surviving Brain Cancer are Minimal.
Just came across a great article on Dr. Henry Brem (from 2005), Director of the Department of Neurosurgery, and Neurosurgeon-in-Chief at The Johns Hopkins University.
Accurexa (ACXA) recently announced it had entered into an exclusive license agreement which allows the company to collaborate with Prof. Brem's outstanding team at Johns Hopkins University - with regards to a composition for treating an individual with a solid tumor comprising a combination of BCNU and temozolomide.
BCNU (carmustine) is a chemotherapy drug that is contained in Gliadel(R), a biodegradable polymer that is implanted locally into the resection cavity after surgical removal of a brain tumor and is indicated for the treatment of newly diagnosed and recurrent GBM.
Temozolomide is a now a generic, approved chemotherapy drug that is indicated for the treatment of glioblastoma multiforme (GBM). Before temozolomide became generic, it generated US sales of $420 million and global sales of $910 million under its brand name Temodar(R) in 2012.
The first glimpse I had of Dr. Henry Brem has stuck with me.
It was in 1987, well before he'd become head of neurosurgery at Johns Hopkins. As a media specialist for Hopkins, I was wedged into a corner of an elevator, watching a man I presumed was Brem on his way to a press conference. He was talking about how he had been placing therapeutic wafers of some sort into the brains of tumor patients. I remember less about the science than Brem's demeanor. Though his voice was soft, it was excited and genuine. He radiated an optimism that left us mesmerized as the doors opened. An E.F. Hutton moment. We'd have bought stock in his technique that afternoon, had it existed.
FULL ARTICLE:
http://biotechstockreview.ning.com/profiles/blogs/the-chances-of-surviving-brain-cancer-are-minimal
How long it takes the FDA to "approve" a 510(k) submission.
Emergo conducted a review of public data on medical devices cleared by the US Food and Drug Administration between January 1, 2010 and December 31, 2014.
The 15,000+ device clearances examined went through the FDA’s Premarket Notification program, more commonly known as the 510(k). This process applies to nearly all Class 2 devices, and a relatively small percentage of Class 1 and 3 devices.
For purposes of analysis we separated the devices into four basic categories:
Traditional 510(k) submissions reviewed by internal FDA staff (72% of all)
Traditional 510(k) submissions reviewed by Third Party Reviewers authorized by the FDA (6% of all)
Special 510(k) submissions (20% of all)
Abbreviated 510(k) submissions (5% of all)
FULL STUDY RESULTS:
http://biotechstockreview.ning.com/profiles/blogs/how-long-it-takes-the-fda-to-approve-a-510-k-submission-1
Who is this mysterious NYSE Member firm?
I see at least five press releases from other companies saying the same thing. ERFB, MLHC, WNTR, KSIH..
https://www.nyse.com/markets/nyse/membership
Anheuser-Busch to offer $106bn for SAB Miller.
Anheuser-Busch InBev (AMIN), the largest brewery company in the world, is all set to make an initial bid close to $106bn (£70bn, €95bn) to acquire Britain-based SAB Miller (SAB), the second-largest brewery company in the world. A possible merger could give Anheuser InBev control over almost one-third of global beer volumes.
SABMiller had confirmed in a public statement on 16 September that Anheuser InBev intended to make a proposal for acquisition. The company said no proposal had yet been received, and revealed no further details about the terms of any such proposal. According to Reuters, the first bid could be made as early as 28 September (Monday).
As of 2014, Anheuser InBev had a combined global share of 20.8% of the beer market while SABMiller had 9.70%. If the deal goes through, Anheuser InBev will rule the global beer market with an estimated 30.5% market share. Some of the most popular brands of beer under Anheuser InBev are Budweiser, Busch, Corona, Hoegaarden, Leffe and Stella Artois, while Miller, Fosters, Peroni, Castle are some of the best known brands under SAB Miller.
According to a Forbes report, the current combined market cap of Anheuser InBev is £135bn (€182bn, $204bn), almost double the market capitalisation of SABMiller which is £58bn (€78bn, $87bn). While SABMiller is listed on the London and Johannesburg stock exchanges, Anheuser InBev is listed on Euronext and the NYSE.
Anheuser InBev's buyout of SABMiller has been a matter of speculation for some time now but could not materialise due to the debt burden of Anheuser InBev which it took to finance multiple mergers and acquisitions in the last few years. Anheuser InBev was formed following acquisition of American brewer Anheuser-Busch by Belgian-Brazilian brewer InBev, which in turn was a merger of AmBev and Interbrew. While the Anheuser Busch and InBev acquisitions cost the company a total of £34bn (€46bn, $52bn) in 2008, for the earlier acquisition of AmBev–Interbrew the company had to shell out £7.5bn (€10bn, $11.5bn) in 2004.
Regulatory hurdles
Agreeing on the sale price will not be the only difficult task. Given the global presence both the companies have, they will have to get regulatory clearances from all associated authorities as well. According to a Bloomberg report, SAB Miller will have to exit its various joint ventures. Among them are its JV with Molson Coors Brewing Co, called MillerCoors in the US, a stake in CR Snow in China and a minority stake in French liquor company Groupe Castel.
The acquisition of SABMiller will be crucial for Anheuser InBev as it looks to spread its reach to emerging and growing markets from the already established and somewhat declining ones. SABMiller dominates the beer industry in Africa and Latin America with over 30% of its revenues coming from there led mainly by South Africa in the last fiscal year. Anheuser-Busch InBev, on the other hand, has negligible footprint in a market like Africa, and this acquisition could drive that growth. Sanford C Bernstein analyst Trevor Stirling in an interview to the Wall Street Journal commenting on a possible deal said: "By acquiring SABMiller, Anheuser-Busch InBev would be buying growth in Latin America and in Africa and buying the opportunity to take a lot of cost out of SAB's back office operations."
http://www.ibtimes.co.uk/anheuser-busch-seen-making-106bn-offer-sab-miller-1521481
A Brewing Bucha (ABRW) Opportunity in the Functional Beverage Space.
REDONDO BEACH, CA / ACCESSWIRE / September 22, 2015 / The craft brewing industry may be struggling amid intensifying competition, with companies like Craft Brew Alliance Inc. (BREW) falling some 36% over the past 52 weeks, but there's another type of brew that has been taking off over the past couple of years.
Kombucha is a brewed and fermented probiotic tea that could grow from $122.7 million in 2013 to upwards of $500 in 2015. In many Whole Foods Inc. (NASDAQ:WFM) stores, for instance, the category accounts for about a third of its refrigerated functional beverage shelf space. The market also remains rather fragmented with only one market leader - GT - and a number of much smaller competitors looking to secure a share of the market.
Despite its introduction thousands of years ago, consumers have just now been embracing kombucha in increasing numbers due to its perceived healing and cleansing characteristics. Kombucha teas include probiotics from the fermentation and a number of potentially beneficial byproducts found in the tea itself, such as polyphenols, antioxidants, and flavonoids. Some manufacturers are also developing coffee, beer, and other styles of kombucha.
In this article, we'll take a look at a company that's leveraging its experience in craft brewing to introduce a revolutionary kombucha product into health and grocery stores nationwide.
Capitalizing on Kombucha
American Brewing Co. Inc. (ABRW) is a Washington-based craft brewer with four beers in its portfolio, including the Flying Monkey Dogfight Pale Ale, Breakaway IPA, American Blonde, and Caboose Oatmeal Stout. After getting its start in the beer industry, the company expanded into the kombucha category with its bucha(TM) Live Kombucha brand of gluten-free, organic, sparkling kombucha teas back in April of 2015 with distribution throughout North America.
When the company was acquired there was distribution into 1800 stores including health, natural and grocery chains. The company is looking to double that store count over the next 12 months with distribution into all major U.S. markets utilizing a new national broker network.
Its proprietary blend differentiates itself from other kombucha producers through its proprietary extraction process that reduces the sour taste and may appeal to a larger audience. In fact, the sour nature of most kombucha could be a leading factor that's holding back wider consumer adoption.
Profitable & Growing
American Brewing reported revenue of $940,007, gross profit of $326,628, and net income of $19,217 during the quarter ended June 30, 2015. Following the acquisition of bucha(TM) Live Kombucha, the company generated 73% of its revenue and 84% of its gross profit from its bucha tea Wholesale division. The oversized impact on gross profit suggests that the transition into kombucha will continue improving overall margins over time.
In terms of near-term potential, investors may want to take a look at Reed's Inc. (NYSE:REED) success in entering the market. Reed's reported second quarter kombucha sales that increased 11% as it worked to improve its production techniques and add additional flavors – including the addition of a coffee-based kombucha. According to their 10-K filing, kombucha has grown to account for about 12% of the company's $43.4 million in net sales - or about $9.5 million.
American Brewing has a market capitalization of just $7 million, which leaves substantial room for upside if can capture just a fraction of the market. Reed's trades with a price-sales ratio of about 1.4x, while many larger beverage companies trade with even higher multiples. The company's pure-play focus on kombucha could lead to an above-market multiple, since it would presumably be able to grow faster than its diversified competitors.
Looking Ahead
Kombucha is the largest growth segment of the functional beverage category of food and drinks, which includes coconut water, yogurts, and fresh juices. The refrigerated juices section of the market alone grew by approximately $200 million in 2012 to an estimated market of about $600 million (50% growth), according to SPINS data. Kombucha accounts for an overwhelming majority of that explosive growth and accounts for a large part of the segment.
With its growing distribution footprint and product innovation, American Brewing is well-positioned to become a virtual-pure-play in the kombucha space. Investors interested in the functional beverage space may want to take a closer look at the stock given these catalysts. In particular, investors in micro-cap functional beverage stocks, like DC Brands International Inc. (OTC Pink: HRDN), or nutraceutical firms, like Nutraceutical Int'l Corp. (NUTR), may want to take an especially close look at the stock.
For more information, visit the company's website at www.americanbrewing.com.
Legal Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.
SOURCE: Emerging Growth LLC
Will SABMiller buy Coca-Cola Amatil Ltd?
Shares of Coca-Cola Amatil Ltd (ASX: CCL) have rallied 18 cents, or 2.1% today to trade at $8.81, compared to a 1.3% lift for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO).
So What: Although the lift could partially be attributed to the general optimism in the market today, it could also be linked to reports that SABMiller, the world’s second-largest brewer, has been approached by its larger rival Anheuser-Busch InBev (AB InBev) regarding a potential takeover.
According to The Australian Financial Review, there has been speculation recently that SABMiller could be interested in acquiring Coca-Cola Amatil given the heavy fall in the Australian-based beverage manufacturer’s shares over the last two years.
An acquisition of Coca-Cola Amatil could also be a strategy to block a takeover by AB InBev’s given AB InBev’s relationship with Pepsi, which could create regulatory issues with the tie-up (more on regulatory hurdles in a moment).
Whether or not the speculation regarding SABMiller’s interest in Coca-Cola Amatil is accurate, the latest takeover assault from AB InBev could certainly add an element of urgency to these rumours.
Still, there is no certainty that a deal between SABMiller and AB InBev will proceed. To begin with, no formal offer has been made just yet with the AFR reporting that AB InBev wants to work with the board of SABMiller “toward a recommended transaction.”
Meanwhile, a tie-up between the two largest brewers would no doubt draw the attention of the regulators. A combination of the two would create one of the world’s biggest companies – dominant in Africa, Asia and America – with a value likely to be north of $320 billion. The company would also produce roughly a third of the world’s beer.
Now What: While it is possible that Coca-Cola Amatil could become a takeover target itself, investors shouldn’t invest in the company based solely on that reason. In saying that however, the company does appear to be trading at quite an attractive price and could be a good investment for investors focused on the long-term.
The smart money is looking for up-and-coming smaller companies with huge potential.
Jones Soda Announces Launch of Limited Edition Halloween Flavors.
SEATTLE--(BUSINESS WIRE)--
Jones Soda Co. (JSDA), a leading premium beverage company known for its unique flavors, today announced the return of Halloween-themed beverages, this year in its classic long neck glass bottles.
Continuing its tradition of spooky themed beverages to represent this holiday, this year’s newly designed Halloween beverages come in two delicious flavors, Blood Orange and Lemon Drop Dead. This year’s packaging, inspired by the vintage look of classic monster movies, is perfect for Halloween-themed celebrations for all ages to enjoy.
“We have so much fun with our Halloween line and are excited to offer it again this year,” stated Andrew Baumann, Director of Marketing, Jones Soda. “It’s a unique offering that tastes great and has amazing packaging that will get everyone in the Halloween spirit!”
The Halloween-themed sodas are available throughout the U.S. at Cost Plus World Market, select Kum & Go locations, numerous independent stores and online at www.jonessoda.com.
Jones Soda Co. Earnings Q2, 2015 Capital Cube q 13 days ago
JONES SODA CO Financials EDGAR Online Financials 1 mth 5 days ago
More
About Jones Soda Co.
Headquartered in Seattle, Washington, Jones Soda Co.® (OTCQB: JSDA) markets and distributes premium beverages under Jones® Soda, Jones Zilch® and Jones Stripped™ brands and sells through its distribution network in markets primarily across North America. A leader in the premium soda category, Jones is known for its variety of flavors and innovative labeling technique that incorporates always-changing photos sent in from its consumers. Jones Soda is sold through traditional beverage retailers.
For more information, visit www.jonessoda.com or www.myjones.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150916006578/en/
American Brewing Announces Completion of Bucha Acquisition.
EDMONDS, WA / ACCESSWIRE / September 8, 2015 / On August 19, American Brewing Company, Inc.(R), (ABRW) ("ABC"), an award-winning micro-brewing company and owner of bucha (TM) live Kombucha, released the company's 10Q for the quarter ended June 30, 2015. This quarterly report also reflected the audited financials of its recent acquisition of bùcha (TM) live Kombucha brand.
The "bucha" brand and its operations are now fully integrated into American Brewing. The transformational accretive acquisition of "bucha" was a result of a 26% dilutive transaction that resulted in an immediate revenue increase of over 300%. Cash and equity were used and the equity is subject to a very shareholder friendly, 18-month leak-out provision. In addition to this, we currently have other exciting deals in the pipeline, both "white label" and "acquisitive" that could have a similar impact on the company. Our lengthy self-imposed quiet period due to the acquisition audit has ended and shareholders can now expect frequent communication.
Excluding one-time charges related to the acquisition, we are now cash flow positive.
Guidance
Based on organic growth, addition of new store locations to existing accounts, accompanied by new accounts, we anticipate fiscal year 2016 revenues to increase roughly 63%. This does not include the beverage deals in our pipeline.
The macro outlook for Kombucha is impressive as well according to KBI, with U.S. sales estimated to grow from $500 million in 2015 to $1.8 billion by 2020. According to the Kombucha Brewers International Union, Kombucha is experiencing 30% growth in the natural channel and 50% growth in the conventional channel. It is the fastest growing functional beverage category. Our búcha brand grew 79% from 2013 to 2014.
We now have the opportunity to capitalize on the established business that bucha(TM) has created over the years, by using our own proprietary processes and great flavors. We already have a significant footprint in Kroger, Safeway and Whole Foods, just to name a few. We anticipate further distribution opportunities along with increasing shelf space, accompanied by more accretive transactions in our pipeline.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. These statements include, without limitation, predictions and guidance relating to the company's future financial performance and the research, development and commercialization of its technologies. In some cases, you can identify forward-looking statements by terminology such as, "may," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "continue," or the negative of these terms or other comparable terminology. These forward-looking statements are based on management's current expectations, but they involve a number of risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements, as the result of such factors, risks and uncertainties as (1) competition in the markets for the products and services sold by the company, (2) the ability of the company to execute its plans, (3) other factors detailed in the company's public filings with the SEC, which are available at http://www.sec.gov/. You are urged to consider these factors carefully in evaluating the forward-looking statements.
Contacts
Corporate:
Neil Fallon, CEO
American Brewing Company (R)
Email: neil@americanbrewing.com
SOURCE: American Brewing Company, Inc.
A window that is also a battery.
A group of Japanese researchers have managed to improve the design of a transparent lithium-ion battery so that it’s now able to recharge itself when exposed to sunlight without the need for a separate solar cell.
The transparent battery was first developed by the researchers, led by Kogakuin University president and professor Mitsunobu Sato, back in 2013. The electrolyte used for the battery’s positive electrode is made mostly from lithium iron phosphate, while the electrolytes used for the negative electrode include lithium titanate, and lithium hexafluorophosphate.
http://gizmodo.com/transparent-batteries-that-charge-in-the-sun-could-repl-1727951349
Party ?
Should we be selecting a "post" decision restaurant location ?
Why wait until the last minute. It's a favorable we'll pop bottles of champagne. If it's unfavorable, we can do shots of Tequila. Either way it would be nice to have company - to chat about what we'll buy with our winnings, or what would would have done with our winnings.
Craft beer brewers just got downgraded to ‘sell’
There’s a lot of noise in the modern beer industry, but if you listen past it, you can hear a story being told.
Earlier this week, Petaluma, Calif.-based Lagunitas Brewing Co. sold a 50% stake to Heineken for an estimated $500 million. Lagunitas founder Tony Magee will tell you, in detail, that it’s simply an acceptance of where craft beer is headed. Magee’s critics will tell you it’s hypocrisy of the highest order from a craft-beer zealot who, just this year, threw down with Sierra Nevada over IPA and kerning. Craft beer’s last remaining hard-liners will say it’s Lagunitas losing its craft credibility under a definition it helped write.
All of the above misses the point.
Within the same week, MillerCoors’ Tenth and Blake division, home to its Blue Moon and Leinenkugel brands, bought two-year-old San Diego brewer Saint Archer, making it the first brewery in a city of more than 100 to be bought out by a major brewer. Some uncharitably called them a brewery built to sell out. Others, especially San Diego Padres fans, questioned their commitment to their hometown.
Again, all part of a fairly indiscernible din obscuring a very strong statement.
We’ve been writing this column for a little less than a year...
http://www.marketwatch.com/story/craft-beer-brewers-just-got-downgraded-to-sell-2015-09-11
Petroleum Economist Awards, Thursday Night.
http://alternativeenergystockreview.ning.com/profiles/blogs/originclear-nominated-for-technology-of-the-year-petroleum
Dr Henry Brem
Henry Brem has developed new tools and techniques that have changed the field of neurosurgery. Brem carried out the pivotal clinical study that introduced navigational imaging into the neurosurgical suite. His work led to the FDA's approval of the first image guidance computer system for intraoperative localization of tumors. Furthermore, he has changed the surgical armamentarium against brain tumors by inventing and developing Gliadel® wafers to intraoperatively deliver chemotherapy to brain tumors. His work has shown that surgeons can accurately deliver potent therapies directly at the tumor site.
At Hopkins, he has built one of the largest brain tumor research and treatment centers in the world. He reinstituted the Hunterian Neurosurgery Laboratory (originally founded by Cushing) and has trained numerous researchers who have revolutionized the fields of intraoperative imaging, angiogenesis, immunotherapy, and controlled release polymers for drug delivery to the brain.
http://www.hopkinsmedicine.org/neurology_neurosurgery/experts/profiles/team_member_profile/EF48C2ECB225F29CCA8C801AAEB2BE26/Henry_Brem
Alternative Energy Stock Review Initiates Coverage.
http://alternativeenergystockreview.ning.com/profiles/blogs/initiating-coverage-on-originclear-ooil-0-04
Covered in Private Equity Stock Review
http://privateequitystockreview.ning.com/
What is Produced Water ?
INTRODUCTION TO PRODUCED WATER
What Is Produced Water?
Produced water is water trapped in underground formations that is brought to the surface along with oil or gas. Because the water has been in contact with the hydrocarbon-bearing formation for centuries, it contains some of the chemical characteristics of the formation and the hydrocarbon itself. It may include water from the reservoir, water injected into the formation, and any chemicals added during the production and treatment processes. Produced water is also called “brine” and “formation water.” The major constituents of concern in produced water are:
*Salt content (salinity, total dissolved solids, electrical conductivity)
*Oil and grease (this is a measure of the organic chemical compounds)
*Various natural inorganic and organic compounds or chemical additives used in drilling and operating the well
*Naturally occurring radioactive material (NORM)
Produced water is not a single commodity. The physical and chemical properties of produced water vary considerably depending on the geographic location of the field, the geological host formation, and the type of hydrocarbon product being produced. Produced water properties and volume can even vary throughout the lifetime of a reservoir.
How Much Produced Water Is Generated?
Produced water is by far the largest volume byproduct or waste stream associated with oil and gas exploration and production.
*Approximately 21 billion bbl (barrels; 1 bbl = 42 U.S. gallons) of produced water are generated each year in the United States from nearly a million wells. This represents about 57 million bbl/day, 2.4 billion gallons/day, or 913,000 m3/day (Clark and Veil 2009).
*More than 50 billion bbl of produced water are generated each year at thousands of wells in other countries.
Early in the life of an oil well, the oil production is high and water production is low. Over time the oil production decreases and the water production increases. Another way of looking at this is to examine the ratio of water-to-oil:
*Worldwide estimate – 2:1 to 3:1
*U.S. estimate – 5.1 to 8:1, because many U.S. fields are mature and past their peak production (Clark and Veil 2009), although the ratio may be even higher.
*Many older U.S. wells have ratios > 50:1
At some point the cost of managing the produced water exceeds the profit from selling the oil. When this point is reached, the well is shut in.
In contrast, a coal bed methane well initially produces a large volume of water, which declines over time. The methane production starts low, builds to a peak, and then decreases.
References
This information and much of the background material used throughout the PWMIS site is based on Argonne’s produced water white paper [external site].
Clark, C.E., and J.A. Veil, 2009, Produced Water Volumes and Management Practices in the United States [external site], ANL/EVS/R-09/1, prepared by the Environmental Science Division, Argonne National Laboratory for the U.S. Department of Energy, Office of Fossil Energy, National Energy Technology Laboratory
Veil, J.A., M.G. Puder, D. Elcock, and R.J. Redweik, Jr., 2004, “A White Paper Describing Produced Water from Production of Crude Oil, Natural Gas, and Coal Bed Methane,” prepared by Argonne National Laboratory for the U.S. Department of Energy, National Energy Technology Laboratory.
http://www.netl.doe.gov/research/coal/crosscutting/pwmis/intro
Will OPEC's Secretary General Give OOIL an Award ?
This is about a prestigious as it gets - and in our opinion (which is much less valuable then the opinion of Petroleum Economist) that OriginClear's (OOIL) technology works. There's not much chance we think you'll agree, of the Petroleum Economist's committee nominating a technology that doesn't work or "kind of" works.
The prestigious Petroleum Economist annual awards ceremony will be held in London on 17 September 2015.The Petroleum Economist Awards aim to celebrate the people, companies and projects which epitomize the best of the energy industry.
http://alternativeenergystockreview.ning.com/profiles/blogs/originclear-nominated-for-technology-of-the-year-petroleum
Welcome Sabby Capital Management as New Shareholder.
S-1 is out.
HC Wainwright brought the venerable Sabby Capital to the table.
http://biotechstockreview.ning.com/profiles/blogs/accurexa-acxa-lands-sabby-capital-as-shareholder